The US biotech company Moderna said last week it is enhancing its AI collaboration with ChatGPT. According to Moderna CEO Stephen Bancel the company has an ambitious plan to launch multiple products over the next few years.
– Collaborations with companies like OpenAI are critical to our ability to scale and maximize our impact on patients, he said in the release.
– Moderna is a digital-first company that has leveraged the power of machine learning since its beginnings. This strong data foundation, along with its robust culture of learning, positions the Company to responsibly and seamlessly integrate generative AI into its operations and capitalize on next-generation AI innovation, the company says.
These GPTs are now embedded across Moderna’s business functions – from legal, to research, to manufacturing, to commercial – and are purpose-built as assistants that work beside Moderna’s employees, augmenting their roles through personalized support.
According to company in the few months since adopting ChatGPT Enterprise, Moderna has deployed more than 750 GPTs across the Company that help drive automation and productivity.
ComteamPUB+ 